The initial clinical description of progressive supranuclear palsy (PSP) by Steele et 14 multiple system atrophy, '5 16 or corticobasal degeneration'7 18 may be a source of diagnostic confusion. Several authors have formulated clinical criteria for the diagnosis of PSP during life'2'3 921; however, none have been based on a large necropsy series. Such diagnostic criteria may be suboptimal in that they have not been subjected to systematic neuropathological validation and furthermore, are necessarily biased toward clinically typical PSP cases.
We report our clinicopathological findings in a consecutive necropsy series of 12 patients with PSP studied at the Mayo Clinic. We confirm neuropathologically the expanded phenotypic diversity of PSP reported by previous authors, and outline clinical criteria formulated from our study to enhance the sensitivity of premortem diagnosis of this condition.
Methods
All patients with the neuropathological diagnosis of PSP (or Steele-Richardson-Olszewski syndrome) based on postmortem pathological examination at the Mayo Clinic were sought. Cases were identified from the neuropathological diagnostic coding files of the Department of Laboratory Medicine and Pathology. Ascertainment was verified by a computer search of all clinically diagnosed cases Certain examination findings were invariably present, including bradykinesia, rigidity, and dysarthria (table 2) . Rigidity was noted in all patients, but was slight in two (cases 3 and 10). Rigidity of the neck (axial) exceeded that in the limbs in eight of the 11 patients examined at the Mayo Clinic. Dysarthria was a presenting complaint in four patients and was characterised by combinations of hypokinetic and spastic features. In nine patients, the examiner specifically commented about the severe degree of facial masking and absence of blinking with terms such as "totally blinkless"; "does not blink"; "fixed stare".
In eight of the patients examined at the Mayo Clinic, the gait was shuffling like that of Parkinson's disease (table 2) ; however, the base was noted to be wide in at least four of these patients, unlike Parkinson's disease. Examiners noted that four patients sat "en bloc", characterised by the patient's feet coming high off the floor as they sat down (table  2) ; this is unusual in idiopathic Parkinson's disease except for patients in very advanced stages. Dystonia was identified in five patients, involving the neck in four. In one patient, antecollis was noted, by contrast with the more typical retrocollis. Although a resting tremor was documented in two patients, it was of low amplitude in each. Cognition was impaired in seven patients, but moderate or severe dementia was noted in only two ( Carbidopa/levodopa (Sinemet) or levodopa alone was given to 10 of the 12 patients. Seven had no or minimal response. Two patients experienced partial improvement in motor symptoms, but this was only transient, lasting less than six months in one (case 4) and about two years in the other (case 5). The response was unknown in one patient. The maximum known daily levodopa dosage ranged from 500 mg to 1500 mg (mean 807 mg) in the seven patients who were given carbidopa/levodopa. One of two patients treated with levodopa without carbidopa received a maximum of 5-5 g daily; the maximum dose was unknown in the other. Other medication-namely, amantadine, amitriptyline, and trihexyphenidyl-were tried in four patients without substantial benefits.
The clinical diagnosis during life was progressive supranuclear palsy in eight of the 12 patients. Diagnoses in the remaining four patients were "atypical PSP" (case 6), "Parkinson's plus, perhaps PSP" (case 12), and "indeterminate extrapyramidal disease" (cases 3 and 1 1).
Cranial CT, performed in nine patients, showed non-specific abnormalities consisting of mild to moderate generalised cerebral atrophy, sometimes in association with mild lateral ventricular dilatation. The neuroradiologists reviewing the scans during the patients' life were not impressed by disproportionate brain stem changes in any of the patients. In two patients (cases 3 and 8), mild to moderate low attenuation changes were noted bilaterally in the deep white matter of the cerebral hemispheres. Magnetic resonance imaging performed in two patients contributed no substantial additional information. When performed, EEG (six patients) and CSF examinations (three patients), showed only minor, non-specific changes.
The most common recognised causes of death were pneumonia (three patients) and respiratory arrests (two patients), with one patient dying from myocardial infarction and one from a massive pulmonary embolism. The cause of death was unknown in five cases.
Discussion
The demographic characteristics of our patient population were similar to previously published series -4 7 12 13 19 20 in that there was a male predominance, symptom onset after age 40, and a disease duration until death that was relatively short (5 3 years). In one third of our patients, the diagnosis was not made with certainty during life; this is consistent with the increasing recognition that the clinical characteristics of PSP extend beyond the homogeneous clinical presentation recorded in the initial series by Steele and colleagues.' 2 Not only are the classic clinical criteria,' 2 insufficient to allow the diagnosis in some atypical cases, but also, the clinical hallmark of PSP, supranuclear ophthalmoparesis, may be present in other neurodegenerative conditions, resulting in diagnostic confusion.'3 171826 Typical of postmortem series, the patient selection was biased toward the atypical; the wide clinical range, however, can serve as a basis for the development of relatively sensitive and specific clinical diagnostic criteria.
Not unexpectedly, early pronounced gait imbalance and supranuclear downgaze paresis were the two signs in this series that were "red flags" for the diagnosis of PSP. Prominent imbalance with frequent falls was a heralding symptom in half of the patients in this series and was a prominent complaint in all by the time three years had elapsed. This contrasts with idiopathic Parkinson's disease in which prominent imbalance occurs much later; only rarely is it severe enough to cause frequent falling within the first five years.
Supranuclear vertical gaze paresis is regarded as the primary clinical hallmark of PSP. Upgaze paresis, however, may be present in normal aging24 and may also be a nonspecific sign in other neurodegenerative conditions including idiopathic Parkinson's disease. Supranuclear downgaze paresis, however, is more specific for PSP, although it occurs in corticobasal degeneration '7 18 and, uncommonly, in other conditions. ' 18 25 and multiple system atrophy. '5 18 Firstly, whereas facial masking is seen in all these conditions, the extremely immobile facies with a wide eyed, blinkless staring expression is very distinctive of PSP.2 Blink rates have been shown to be substantially less in patients with PSP, compared with all but those with most advanced Parkinson's disease.27 In the present series, the facies were sufficiently distinctive in nine of the 11 Mayo Clinic patients to cause the clinicians to comment specifically in terms such as "totally blinkless", "reptilian stare", "non-moving facies." Perhaps the combination of extrapyramidal plus corticobulbar dysfunction is the reason for the distinctive facies in PSP.
PSP also differs from idiopathic Parkinson's disease and most other neurodegenerative disorders in that the motor deficits are more axial than appendicular. This was exemplified in the present series in which neck rigidity was given a more severe rating than limb rigidity in most patients, opposite to that typically seen in Parkinson's disease. Axial movements of the body are also performed extremely slowly and stiffly in classic cases of PSP, prompting Steele and colleagues to characterise this in certain of their patients as "apraxia" of truncal turning and sitting.' 2 This "truncal apraxia" is often most apparent when the patient with PSP is asked to sit and subsequently plops backward on to the seat "en bloc" with feet rising high off the floor; this was described in four of the patients in this series.
Although a shuffling gait in PSP may resemble that of idiopathic Parkinson's disease, it is more typically wide based, as noted in four of the five patients in which this specific information was recorded. As already mentioned, the tendency to move "en bloc" and the prominent and early imbalance also distinguish the classic PSP gait from that of idiopathic Parkinson's disease.
Whereas a prominent resting tremor is highly characteristic of idiopathic Parkinson's disease, it is either absent2 or of slight amplitude in PSP.4 28 Although two patients in this series displayed a resting tremor, it was clear from the records that this was of low amplitude and not prominent. Thus although a mild resting tremor does not exclude PSP, a pronounced resting tremor argues against this diagnosis.
Symmetric onset of clinical signs is also characteristic of PSP, by contrast with idiopathic Parkinson's disease and corticobasal degeneration'7 18 25 in which the signs typically are asymmetric and even unilateral. The symmetry is not invariant, however, as found in the present series in which moderate asymme-try was noted in two patients and mild asymmetry in an additional four. Unilateral or predominantly unilateral motor deficits, however, suggest a diagnosis other than PSP.
The response to levodopa also distinguishes PSP from idiopathic Parkinson's disease. Whereas patients with PSP occasionally respond,20 29 the improvement is typically short lived and insufficient to alter major disability. 29 Similarly, two of our cases responded to levodopa, but with no more than moderate and short lived benefit. Thus lack of an impressive sustained improvement with levodopa is an important diagnostic clue.
Dystonia is a non-specific clinical sign; however, dystonia of the neck, especially retrocollis,' as well as arm dystonia,'0 may suggest PSP in the proper clinical context. In the present series, retrocollis or arm dystonia were present in four patients. Although lower limb dystonia is common in untreated Parkinson's disease, arm dystonia or retrocollis is uncharacteristic. Whereas corticobasal degeneration is characterised by a stiff, dystonic limb'7 18 25 neck dystonia, particularly retrocollis, is exceptional.
Corticobulbar signs as well as corticospinal tract signs are also highly characteristic of PSP, as exemplified in the present series. The strained, harsh quality of the voice, characteristic of a spastic dysarthria, is not present in idiopathic Parkinson's disease, although it does occur in multiple system atrophy. '5 Whereas dysphagia and a pseudobulbar affect can occur late in Parkinson's disease, these are relatively earlier signs in PSP. Babinski signs, which are unexpected in Parkinson's disease, were documented in 75% of patients in this series. Cognitive impairment was noted in most of our patients, but was severe in only two. Personality changes may herald the development of cognitive impairment.2 Although dementia is a frequent occurrence in certain other neurodegenerative disorders such as Parkinson's disease, it is rare in others, specifically multiple system atrophy'5; in certain cases this may be a useful clinical distinguishing feature.
Prominent and early dysautonomia was not seen in the present series and its absence may be a useful clinical clue. Although the autonomic nervous system is known to be compromised in PSP, it is not severely impaired.30 Thus although bowel and bladder dysfunction were frequent problems in end stage disease in this series, symptomatic orthostatic hypotension was not encountered except for a single transient episode in one patient due to dehydration.
Ideomotor apraxia of the limbs is thought to reflect a cortical deficit and is not an expected finding in PSP, in which the pathology is largely confined to subcortical structures. None the less, two patients from the present series displayed ideomotor limb apraxia. In one patient (case 12), the asymmetric apraxia was sufficient to raise the possibility of corticobasal degeneration. The clinician (DMM), however, noted that the apraxia was not as pronounced, nor was the asymmetry as prominent, as in typical corticobasal degeneration. Several other signs suggested PSP as a more likely diagnosis including a "fixed stare" and the early development of imbalance with frequent falls. An alien limb sign, which is frequent in corticobasal degeneration '7 18 was not identified in case 12, although sought. Whereas downgaze paresis was noted in this patient, this sign is also frequent in corticobasal degeneration. '7 18 As reported by Gibb et al,'7 a clinical distinction between PSP and corticobasal degeneration may be extremely difficult to make in occasional patients.
Although upper limb ideomotor apraxia is classically attributed to cortical dysfunction, no distinctive neuropathological abnormalities sufficient to account for this sign were identified in the cortex of our two apractic patients. This is analagous to the findings of Davis et al in two patients with PSP with severe dementia suggesting cortical involvement, but without cortical pathology.5 Positron emission tomography studies in patients with PSP have shown functional (hypometabolic) compromise of the cortex, especially frontal, but sometimes including the parietal cortex, presumably secondary to loss of subcortical activation. 3' 33 Various dyskinesiae can occasionally be seen in patients with PSP.12 Myoclonus was noted in two patients in the present series, whereas chorea and oral dyskinesiae, unrelated to medications, were found in additional single patients.
Pure akinesia unresponsive to levodopa (akinesia without rigidity or tremor) has been described as a presenting and sometimes persisting manifestation of PSP in certain Japanese patients.89 Two patients in the present series were a close fit with the dopa unresponsive pure akinesia syndrome (cases 3 and 10); although rigidity was noted in these two patients, it was graded as mild and distinctly disproportionate to the other motor manifestations, as well as being anatomically limited to one arm (case 3) or the neck (case 10).
Although not found in the present series, other authors have noted several additional signs in patients clinically diagnosed with PSP, including dysphasia,6 12 and internuclear ophthalmoplegia,612 as well as various other oculomotor disorders. 37 Head scanning is an appropriate diagnostic procedure in patients with suspected PSP. The primary utility is to exclude structural lesions that might be contributing to the clinical picture as well as multi-infarct states or hydrocephalus, which have been reported to produce clinical findings similar to PSP. '4 Whether these studies can provide PSP specific clues is debatable; various signs of brain stem atrophy have been shown by MRI in some patients with PSP. '4 34 36 37 None the less, we believe that the vast majority of patients with PSP, including most of the clinically diverse, can be correctly diagnosed in life and we offer the algorithm shown in the figure as a means of making the correct diagnosis. Ultimately, the specificity and sensitivity of this diagnostic algorithm must be tested in subsequent series of pathologically confirmed PSP and other akinetic-rigid syndromes.
